LSTA
NASD Lisata Therapeutics, Inc.$1.21 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.21, $0.11 below the day’s high of $1.32
- YTD change
- -34.95%
- vs 20-day SMA
- -22.50%
- vs 200-day SMA
- -60.74%
Price ranges
Price & Performance
-3.74 (-74.80%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 87.1% away from all-time highs of $9.38
- LSTA is down 35% since the beginning of the year
- LSTA is down 52% over the past 12 months
- LSTA is down 27% over the past 1 month
- 2% of all LSTA investors are betting against LSTA
LSTA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -49.8%.
- Previous minute
- +$0.00
- Last hour
- +$0.02
- Last 5 days
- -19.33%
- vs 8-day SMA
- -17.34%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors. The company was founded in 1980 and is headquartered in Basking Ridge, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
